Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
المؤلفون الرئيسيون: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Frontiers Media
2021
|
مواد مشابهة
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
حسب: Helen L. Stark, وآخرون
منشور في: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
حسب: Alzhrani, AI
منشور في: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
حسب: Honeyman, C, وآخرون
منشور في: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
حسب: Honeyman, C, وآخرون
منشور في: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
حسب: Maja-Theresa Dieterlen, وآخرون
منشور في: (2021-08-01)